Bluesky Facebook Reddit Email

Innovative treatment for parasites affecting 1.5 billion people shows safety and superior efficacy in phase II-III trial

01.10.25 | Mundo Sano España

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

The Lancet Infectious Diseases

10.1016/S1473-3099(24)00669-8

Randomized controlled/clinical trial

People

Albendazole–ivermectin co-formulation for the treatment of Trichuris trichiura and other soil-transmitted helminths: a randomised phase 2/3 trial

10-Jan-2025

Jaime Algorta is employee of Laboratorios Liconsa. All other authors declare no competing interests

Additional Media

Video animation explains the importance of the results of this phase II/III clinical trial in advacing a novel drug that can help achieve the control goals set by WHO's 2021-2030 Roadmap for the intestinal parasites known as soil-transmitted helminths (STH) Credit: STOP2030.org

Keywords

Drug Combinations Medical Parasitology

Article Information

Journal
The Lancet Infectious Diseases
DOI
10.1016/S1473-3099(24)00669-8
Method of Research
Randomized controlled/clinical trial
Subject of Research
People
Article Publication Date
2025-01-10
Article Title
Albendazole–ivermectin co-formulation for the treatment of Trichuris trichiura and other soil-transmitted helminths: a randomised phase 2/3 trial
COI Statement
Jaime Algorta is employee of Laboratorios Liconsa. All other authors declare no competing interests

Contact Information

Borja Robert
Mundo Sano España
borja.robert@mundosano.org

Source

Original Source
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00669-8/fulltext

How to Cite This Article

APA:
Mundo Sano España. (2025, January 10). Innovative treatment for parasites affecting 1.5 billion people shows safety and superior efficacy in phase II-III trial. Brightsurf News. https://www.brightsurf.com/news/LRDPO6G8/innovative-treatment-for-parasites-affecting-15-billion-people-shows-safety-and-superior-efficacy-in-phase-ii-iii-trial.html
MLA:
"Innovative treatment for parasites affecting 1.5 billion people shows safety and superior efficacy in phase II-III trial." Brightsurf News, Jan. 10 2025, https://www.brightsurf.com/news/LRDPO6G8/innovative-treatment-for-parasites-affecting-15-billion-people-shows-safety-and-superior-efficacy-in-phase-ii-iii-trial.html.